current
practic
diagnosi
infect
reli
pcr
test
nasopharyng
respiratori
specimen
symptomat
patient
high
epidemiolog
risk
test
strategi
like
underestim
true
preval
infect
creat
need
serolog
method
detect
infect
miss
limit
test
date
describ
develop
coronaviru
antigen
microarray
contain
immunolog
signific
antigen
addit
sarscov
merscov
common
human
coronaviru
strain
common
respiratori
virus
preliminari
studi
human
sera
collect
prior
pandem
demonstr
overal
high
igg
reactiv
common
human
coronavirus
low
igg
reactiv
epidem
coronavirus
includ
crossreact
conserv
antigen
domain
includ
domain
spike
protein
nucleocapsid
protein
array
use
answer
outstand
question
regard
infect
includ
whether
baselin
serolog
coronavirus
impact
diseas
cours
antibodi
respons
infect
develop
time
antigen
would
optim
vaccin
develop
novel
coronaviru
strain
origin
wuhan
china
becom
worldwid
pandem
signific
morbid
mortal
estim
confirm
case
current
case
definit
confirm
due
infect
reli
pcrposit
nasopharyng
respiratori
specimen
test
larg
determin
presenc
fever
respiratori
symptom
individu
high
epidemiolog
risk
howev
case
definit
like
underestim
preval
infect
individu
develop
subclin
infect
produc
fever
respiratori
symptom
unlik
test
test
pcr
nasopharyng
respiratori
specimen
unlik
sensit
detect
subclin
infect
widespread
test
within
unit
state
also
sever
limit
lack
avail
test
kit
test
capac
limit
avail
public
privat
laboratori
therefor
true
preval
infect
current
unknown
sensit
pcr
detect
infect
also
unknown
serolog
play
import
role
defin
preval
sensit
pcr
infect
particularli
subclin
infect
point
demonstr
analog
influenza
viru
metaanalysi
avail
literatur
measur
fraction
asymptomat
infect
detect
pcr
approxim
fraction
asymptomat
infect
detect
seroconvers
measur
approxim
seropreval
common
human
coronavirus
known
increas
throughout
childhood
near
adolesc
thu
serolog
methodolog
estim
preval
need
identifi
rule
crossreact
common
human
coronaviru
strain
one
challeng
appli
serolog
choic
antigen
choic
assay
less
well
defin
coronaviru
well
studi
virus
influenza
howev
prior
approach
serolog
detect
infect
emerg
coronavirus
includ
sar
mer
focus
domain
spike
glycoprotein
nucleocapsid
n
protein
consid
immunodomin
antigen
virus
particular
domain
strainspecif
n
protein
show
crossreact
across
strain
assay
methodolog
use
serolog
detect
coronaviru
infect
includ
bind
neutral
assay
methodolog
shown
well
correl
howev
neutral
assay
requir
viral
cultur
must
perform
highlevel
biosafeti
contain
unit
emerg
coronavirus
high
epidem
potenti
convers
bind
assay
elisa
readili
perform
wide
avail
reagent
equip
field
deploy
suitabl
point
care
test
protein
microarray
methodolog
wide
use
simultan
perform
bind
assay
hundr
antigen
print
onto
nitrocelluloseco
slide
detect
multipl
antibodi
isotyp
methodolog
recent
demonstr
simultan
measur
igg
iga
antibodi
antigen
divers
strain
subtyp
influenza
methodolog
previous
appli
detect
antibodi
domain
sar
mer
coronavirus
blood
specimen
use
studi
collect
larger
studi
resid
colleg
resid
commun
eastern
univers
monitor
prospect
identifi
acut
respiratori
infect
ari
case
use
questionnair
rtqpcr
character
contagi
phenotyp
includ
social
connect
built
environ
immunolog
phenotyp
among
deidentifi
blood
specimen
futur
research
use
author
obtain
five
specimen
show
high
igg
reactiv
human
coronavirus
larger
studi
chosen
valid
coronaviru
antigen
microarray
coronaviru
antigen
microarray
use
investig
includ
antigen
across
subtyp
express
either
baculoviru
cell
see
tabl
antigen
provid
sino
biolog
inc
wayn
pa
either
catalog
product
servic
product
antigen
print
onto
microarray
probe
human
sera
analyz
previous
describ
figur
briefli
lyophil
antigen
reconstitut
concentr
mgml
phosphatebuff
salin
pb
tpb
print
onto
nitrocelluloseco
slide
grace
bio
lab
gbl
bend
use
omnigrid
microarray
printer
genemachin
microarray
slide
probe
human
sera
dilut
gv
fast
block
buffer
fischer
scientif
overnight
wash
ttb
buffer
mm
trishcl
mm
nacl
adjust
ph
filter
time
minut
label
secondari
antibodi
human
igg
conjug
quantum
dot
fluorophor
hour
room
temperatur
wash
ttb
time
minut
dri
slide
imag
use
arraycam
imag
grace
bio
lab
bend
measur
backgroundsubtract
median
spot
fluoresc
nonspecif
bind
secondari
antibodi
subtract
use
salin
control
mean
fluoresc
replic
spot
antigen
use
analysi
descript
statist
use
summar
igg
reactiv
measur
mean
fluoresc
across
antigen
replic
ttest
ftest
use
test
mean
differ
continu
variabl
across
infect
group
statist
analys
conduct
use
r
version
r
foundat
statist
comput
vienna
austria
overal
sera
test
coronaviru
antigen
microarray
show
high
igg
seroreact
antigen
common
human
coronavirus
respiratori
virus
known
season
circul
versu
low
igg
seroreact
antigen
epidem
virus
circul
time
collect
figur
specif
sera
show
high
igg
seroreact
across
common
human
coronavirus
sera
show
low
igg
seroreact
sarscov
merscov
sera
show
high
igg
seroreact
rsv
parainfluenza
virus
sera
show
high
igg
seroreact
adenovirus
influenza
sera
show
high
igg
seroreact
influenza
influenza
b
strain
low
igg
seroreact
influenza
strain
respect
specif
antigen
domain
spike
protein
includ
receptorbind
domain
rbd
demonstr
low
crossreact
epidem
coronavirus
common
human
coronavirus
wherea
domain
spike
protein
nucleocapsid
protein
np
show
lowlevel
crossreact
coronaviru
subtyp
similarli
head
domain
influenza
hemagglutinin
crossreact
season
avian
influenza
strain
wherea
stalk
domain
crossreact
influenza
viru
subgroup
seen
influenza
virus
pilot
studi
yield
sever
insight
crossreact
common
human
coronaviru
antibodi
antigen
antibodi
rbd
domain
spike
protein
highli
subtypespecif
consist
high
variabl
sequenc
differ
human
coronavirus
convers
domain
spike
protein
np
protein
crossreact
consist
sequenc
highli
conserv
across
coronavirus
caus
worldwid
pandem
despit
like
preexist
crossreact
antibodi
domain
np
protein
peopl
indic
antibodi
like
protect
wherea
antibodi
rbd
domain
like
protect
observ
favor
vaccin
strategi
base
rbd
domain
spike
protein
vaccin
strategi
also
includ
domain
np
protein
addit
rbd
domain
like
gener
subtypespecif
serolog
test
popul
surveil
studi
addit
key
unexplain
find
epidem
low
incid
infect
children
age
younger
observ
gener
two
relat
hypothes
adult
may
preexist
antibodi
antigen
distinct
coronavirus
produc
ineffect
humor
respons
infect
antibodydepend
enhanc
demonstr
dengu
viru
children
younger
may
initi
encount
coronaviru
close
relat
protect
infect
immunolog
imprint
origin
antigen
sin
demonstr
influenza
viru
hypothes
would
inform
compar
level
crossreact
coronaviru
antibodi
pediatr
adult
cohort
correl
antibodi
incid
sever
diseas
coronaviru
antigen
microarray
construct
antigen
epidem
coronavirus
includ
common
human
coronavirus
addit
common
respiratori
virus
pilot
studi
human
sera
show
high
igg
seroreact
common
human
coronavirus
low
igg
seroreact
crossreact
seen
domain
spike
protein
nucleocapsid
protein
studi
need
includ
convalesc
sera
fulli
realiz
potenti
novel
methodolog
character
seropreval
impact
preexist
crossreact
antibodi
diseas
cours
